1. 4β‐Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State. Issue 1 (5th November 2016) Authors: Wollmann, BM; Syversen, SW; Lie, E; Gjestad, C; Mehus, LL; Olsen, IC; Molden, E Journal: Clinical and translational science Issue: Volume 10:Issue 1(2017) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CPC-114 Prevalence and Management of Drug-Related Problems in an Intensive Care Unit. (12th March 2013) Authors: Lundereng, K; Sund, JK; Sporsem, HM; Pedersen, R; Molden, E Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of OATP1B1, MDR1 and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects. Issue 4 (16th March 2015) Authors: Ulvestad, M; Skottheim, I. B.; Signe Jakobsen, G; Bremer, S; Molden, E; Åsberg, A; Hjelmesæth, Jøran; Andersson, T. B.; Sandbu, R; Christensen, H Journal: Clinical pharmacology & therapeutics Issue: Volume 97:Issue 4(2015:Apr.) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects. Issue 3 (27th December 2012) Authors: Ulvestad, M; Skottheim, I B; Jakobsen, G S; Bremer, S; Molden, E; Åsberg, A; Hjelmesæth, J; Andersson, T B; Sandbu, R; Christensen, H Journal: Clinical pharmacology & therapeutics Issue: Volume 93:Issue 3(2013) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗